Nationwide Fund Advisors’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-9,390
| Closed | -$12.6M | – | 729 |
|
|
2017
Q3 | $12.6M | Buy |
9,390
+798
| +9% | +$1.07M | 0.05% | 519 |
|
|
2017
Q2 | $6.94M | Buy |
8,592
+5,457
| +174% | +$4.41M | 0.03% | 837 |
|
|
2017
Q1 | $1.93M | Buy |
3,135
+121
| +4% | +$74.6K | 0.01% | 1413 |
|
|
2016
Q4 | $1.61M | Sell |
3,014
-38
| -1% | -$20.3K | 0.01% | 1516 |
|
|
2016
Q3 | $1.58M | Buy |
3,052
+250
| +9% | +$129K | 0.01% | 1514 |
|
|
2016
Q2 | $1.15M | Buy |
2,802
+116
| +4% | +$47.6K | 0.01% | 1641 |
|
|
2016
Q1 | $1.45M | Buy |
2,686
+622
| +30% | +$336K | 0.01% | 1506 |
|
|
2015
Q4 | $1.57M | Buy |
2,064
+16
| +0.8% | +$12.2K | 0.01% | 1476 |
|
|
2015
Q3 | $1.12M | Buy |
2,048
+809
| +65% | +$443K | 0.01% | 1671 |
|
|
2015
Q2 | $728K | Buy |
1,239
+968
| +357% | +$569K | ﹤0.01% | 2037 |
|
|
2015
Q1 | $213K | Sell |
271
-11
| -4% | -$8.65K | ﹤0.01% | 2658 |
|
|
2014
Q4 | $192K | Buy |
+282
| New | +$192K | ﹤0.01% | 2660 |
|